Key result
Higher EASIX links to ~41% greater odds of elevated 10-year ASCVD risk, attenuated by genistein.
Why the study?
EASIX has been proposed as a marker of endothelial stress and may be associated with ASCVD risk, but whether urinary genistein modifies this association remains unclear.
Does higher EASIX score associate with elevated estimated 10-year ASCVD risk classification in adults without prior CVD, and is this modified by urinary genistein?
Cross-Sectional (n=4,478)
Does higher EASIX score associate with elevated estimated 10-year ASCVD risk classification in adults without prior CVD, and is this modified by urinary genistein?
Odds Ratio: 1.407 (95% CI 1.208–1.64)
p-value: p=<0.001
Higher EASIX scores are associated with an elevated estimated 10-year ASCVD risk, an association that is slightly attenuated in individuals with higher urinary genistein levels.
Hypothesis-generating for EASIX-ASCVD link with genistein modification; prospective studies needed before clinical consideration.
BACKGROUND: The Endothelial Activation and Stress Index (EASIX) has been proposed as a marker of endothelial stress and may be associated with atherosclerotic cardiovascular disease (ASCVD) risk. Whether urinary genistein modifies this association remains unclear. METHODS: Multivariable logistic regression examined the association between EASIX and estimated 10-year ASCVD risk classification. Effect modification by urinary genistein (<54.105 vs. ≥ 54.105 μg/g) was assessed using interaction terms and stratified analyses. Restricted cubic splines (RCS) evaluated dose-response relationships. RESULTS: In the fully adjusted model, higher EASIX was independently associated with increased ASCVD risk (OR per unit increase = 1.407; 95% CI: 1.208-1.640; P < 0.001). A significant multiplicative interaction between EASIX and genistein was observed (OR = 1.66; 95% CI: 1.17-2.35; P = 0.005). Stratified analysis showed that this adverse association was slightly attenuated in the higher genistein group (OR = 1.360; 95% CI: 1.066-1.736; P = 0.015) compared to the lower group (OR = 1.397; 95% CI: 1.202-1.624; P < 0.001). RCS analyses showed a non-linear S-shaped association in the lower-genistein group (P nonlinear = 0.020), whereas a predominantly linear relationship was observed in the higher-genistein group (P nonlinear = 0.108). CONCLUSIONS: Higher EASIX was associated with elevated estimated 10-year ASCVD risk classification, and this association differed across urinary genistein strata. These findings should be interpreted as hypothesis-generating.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) conducted a cross-sectional in Atherosclerotic cardiovascular disease (ASCVD) risk (n=4,478). Endothelial Activation and Stress Index (EASIX) vs. Lower EASIX was evaluated on Elevated estimated 10-year ASCVD risk classification (≥7.5%) (OR 1.407, 95% CI 1.208-1.640, p=<0.001). Higher EASIX was independently associated with increased odds of elevated estimated 10-year ASCVD risk (OR 1.407), an association that was slightly attenuated in those with higher urinary genistein.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: